PPARGC1A and type 2 diabetes mellitus: Interestingly, we found that, in overweight/obese individuals with T2D exhibiting higher adverse CVD risk, the −1N was positioned over a regulatory epigenetic site in the PGC1α promoter [7], which may be dependent on nucleosome positioning [10].